Cite
HARVARD Citation
Taurin, S. et al. (2018). Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. International journal of gynecological cancer. 28 (1), p. . [Online].